Galanin (1-13) -spantide I

CC(C)C[C@@H](C(N)=O)NC([C@H](CC(C)C)NC([C@@H](CC1=CNC2=CC=CC=C12)NC([C@H](CC3=CC=CC=C3)NC([C@H](NC([C@H](CCC(N)=O)NC([C@H](CCC(N)=O)NC([C@H]4N(CCC4)C([C@H](CCCCN)NC([C@H]5N(CCC5)C([C@@H](CCCNC(N)=N)NC([C@H]6N(CCC6)C(CNC([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@@H](NC(CNC([C@H](C)NC([C@H](CO)NC([C@H](CC(N)=O)NC([C@H](CC(C)C)NC([C@H]([C@H](O)C)NC([C@@H](NC(CN)=O)CC7=CNC8=CC=CC=C78)=O)=O)=O)=O)=O)=O)=O)CC9=CC=C(C=C9)O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CC%10=CNC%11=CC=CC=C%10%11)=O)=O)=O)=O

[1]Crawley J N, et al. Galanin receptor antagonists M40 and C7 block galanin-induced feeding[J]. Brain research, 1993, 600 (2) : 268-272.|[2]Xu X J, et al. New high affinity peptide antagonists to the spinal galanin receptor[J]. British journal of pharmacology, 1995, 116 (3) : 2076-2080.